SMALL CELL LUNG CANCER EXTENSIVE STAGE

This adverse event was reported 115 times

These drugs are most commonly taken by patients reporting SMALL CELL LUNG CANCER EXTENSIVE STAGE:

# Drug Count
0 ETOPOSIDE 17
1 ATEZOLIZUMAB 12
2 CARBOPLATIN 12
3 METHOTREXATE 10
4 METHOTREXATE SODIUM 10
5 CISPLATIN 9
6 ALBUTEROL SULFATE 6
7 ETANERCEPT 6
8 INFLIXIMAB 6
9 ONDANSETRON HYDROCHLORIDE 6
See all common drugs associated with SMALL CELL LUNG CANCER EXTENSIVE STAGE

SMALL CELL LUNG CANCER EXTENSIVE STAGE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOPOTECAN HYDROCHLORIDE 3 0.0012
1 ESTAZOLAM 1 0.0005
2 AMINOPHYLLINE 1 0.0005
3 AMOXICILLIN AND CLAVULANATE POTASSIUM 2 0.0004
4 PEGFILGRASTIM 5 0.0004
5 AMIFAMPRIDINE PHOSPHATE 1 0.0003
6 TOPOTECAN 2 0.0003
7 ERLOTINIB HYDROCHLORIDE 4 0.0003
8 ATEZOLIZUMAB 12 0.0003
9 DEXAMETHASONE SODIUM PHOSPHATE 3 0.0003
See all drugs enriched for association with SMALL CELL LUNG CANCER EXTENSIVE STAGE